Diabetic Retinopathy
Showing NaN - NaN of 10
Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)
Recruiting
- Diabetic Retinopathy
- Runcaciguat (BAY1101042)
- Placebo
-
Redlands, California
- +85 more
Jan 30, 2023
Diabetic Retinopathy Trial in Spain, United Kingdom, United States (BI 765128, Sham comparator)
Recruiting
- Diabetic Retinopathy
- BI 765128
- Sham comparator
-
Dothan, Alabama
- +34 more
Jan 24, 2023
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-149 dose level 1, THR-149 dose level 2, THR-149
Recruiting
- Diabetes Mellitus
- +2 more
- THR-149 dose level 1
- +6 more
-
Beverly Hills, California
- +60 more
Aug 9, 2022
Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone
Enrolling by invitation
- Non-exudative Age-related Macular Degeneration
- +4 more
- CD34+ bone marrow stem cells intravitreal
-
Sacramento, CaliforniaUniversity of California Davis
Aug 8, 2022
Diabetic Retinopathy Trial in Puerto Rico, United States (PDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal
Active, not recruiting
- Diabetic Retinopathy
- PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
- Intravitreal Ranibizumab 0.5 mg Injection
-
Dothan, Alabama
- +75 more
Aug 3, 2022
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-687 dose level 1, THR-687 dose level 2, THR-687
Terminated
- Diabetes Mellitus
- +2 more
- THR-687 dose level 1
- +3 more
-
Huntington Beach, California
- +24 more
Jul 19, 2022
Choroidal Neovascularization, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (PF-04523655 (Stratum I),
Completed
- Choroidal Neovascularization
- +2 more
- PF-04523655 (Stratum I)
- +2 more
-
Phoenix, Arizona
- +50 more
Feb 3, 2015
